Secnizol DS Tablet 1000 mg is an antimicrobial and antiprotozoal medication used to treat bacterial and protozoal infections. Developed by Sanofi in the 1970s, Secnizol DS Tablet 1000 mg is a nitroimidazole derivative that works by disrupting DNA synthesis in susceptible organisms.
Secnizol DS Tablet 1000 mg is used to treat bacterial and protozoal infections. It is used to treat bacterial dysentery, urinary tract infections, trichomoniasis, giardiasis, and bacterial vaginosis. It is also used to treat trichomonadal infections. In some countries, Secnizol DS Tablet 1000 mg is used off-label as an antifungal drug.
| Brand Name | Secnizol DS |
|---|---|
| Type | Tablet |
| Weight | 1000 mg |
| Generic | Secnidazole |
| Manufacturer | Incepta Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Secnizol DS Tablet 1000 mg acts as an antimicrobial and antiprotozoal agent by interfering with DNA synthesis of susceptible organisms. It binds to the intranuclear enzyme of protozoa, causing disruption of the strands of DNA. This inhibits the synthesis and helical arrangement of the DNA double helix. Secnizol DS Tablet 1000 mg also works to interact with regulatory proteins, leading to additional inhibition of DNA replication.
Secnizol DS Tablet 1000 mg begins to work soon after it is taken. In most cases, a single dose is enough to treat an infection. The time taken to completely cure an infection depends on the type and severity of the infection, as well as the dosage and individual response to the medication.
Secnizol DS Tablet 1000 mg is rapidly and well absorbed following oral administration. The peak plasma concentration of the drug is seen within 1-2 hours after administration. The extent of absorption is not affected by food.
Secnizol DS Tablet 1000 mg is eliminated mainly via the hepatic route. Around 60-77% of the dose is eliminated via the bile. The remainder is eliminated in the urine.
The usual adult dosage of Secnizol DS Tablet 1000 mg is a single dose of 2g (2000mg). The dosage can be adjusted for pediatric patients, taking into account their weight and body surface area. It is important to follow the dosage as prescribed by the doctor to ensure complete treatment.
Secnizol DS Tablet 1000 mg is taken orally, either with food or without food. It is important to take the medication as directed, at the same time each day, to ensure complete treatment.
Common side effects of Secnizol DS Tablet 1000 mg include nausea, vomiting, abdominal pain, dizziness, and headache. Serious side effects include blurred vision, jaundice, rash, and seizures. It is important to contact a doctor immediately if any of these side effects occur.
Secnizol DS Tablet 1000 mg is generally well-tolerated but long-term use of the medication can lead to serious toxic effects. These include hepatic toxicity, neurological impairment, and kidney damage. If any of these occur, it is important to seek medical attention immediately.
Secnizol DS Tablet 1000 mg should be used with caution in pregnant and lactating women, patients with renal impairments, and those taking other medications. It is important to inform the healthcare provider of all the medications being taken to avoid any potential risks or complications.
Secnizol DS Tablet 1000 mg can interact with other medications, including certain antibiotics, antifungals, anticoagulants, and nonsteroidal anti-inflammatory drugs (NSAIDs). These potential interactions should be discussed with a doctor prior to taking Secnizol DS Tablet 1000 mg.
Secnizol DS Tablet 1000 mg can interact with certain medical conditions, including kidney and liver disease, and any other infections. It is important to inform the healthcare provider of any existing medical condition prior to taking the medication.
Secnizol DS Tablet 1000 mg can interact with certain medications, including certain antibiotics, antifungals, anticoagulants, and nonsteroidal anti-inflammatory drugs (NSAIDs). These potential interactions should be discussed with a doctor prior to taking Secnizol DS Tablet 1000 mg.
Secnizol DS Tablet 1000 mg does not interact with food. food does not affect the absorption of Secnizol DS Tablet 1000 mg.
Secnizol DS Tablet 1000 mg should not be used during pregnancy except in very rare circumstances where the potential benefits outweigh the risk to the fetus. It is important to consult a doctor before taking the medication if pregnant.
Secnizol DS Tablet 1000 mg is excreted in breast milk. Therefore, it should be used with caution in breastfeeding mothers and the potential risks should be discussed with a doctor.
In case of an acute overdose, it is important to contact a doctor immediately. Symptoms of an overdose may include nausea, vomiting, abdominal pain, dizziness, and headache.
Secnizol DS Tablet 1000 mg should not be used in patients with a known hypersensitivity to the medication. It should also not be used in combination with other nitroimidazole derivatives.
Secnizol DS Tablet 1000 mg should be taken as directed by the doctor. Take it at the same time each day, with or without food, according to the doctor's instructions. Do not take more or less than the prescribed dose in any given time period.
Store Secnizol DS Tablet 1000 mg at room temperature, away from light and moisture. Keep it out of the reach of children and pets. Do not use the medication if it has expired or if it has been damaged.
The volume of distribution for Secnizol DS Tablet 1000 mg ranges from 0.1-0.3 L/kg. This indicates a large tissue distribution for the drug.
The half-life of Secnizol DS Tablet 1000 mg is 3-6 hours, with a peak plasma concentration of the drug seen within 1-2 hours after administration.
The clearance of Secnizol DS Tablet 1000 mg is 5.4-6.4 L/hr and is primarily determined by the hepatic route.
See in details version Secnizol DS Tablet 1000 mg also Secnizol DS Tablet 1000 mg in bangla
Prof. Dr. Md. Shahidur Rahman
Physical Medicine (Pain, Arthritis, Paralysis) & Rehabilitation Specialist